LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Moderna Inc

Closed

SectorHealthcare

27.46 5.21

Overview

Share price change

24h

Current

Min

26.09

Max

27.54

Key metrics

By Trading Economics

Income

149M

-971M

Sales

-859M

107M

P/E

Sector Avg

35.86

51.198

EPS

-2.52

Profit margin

-907.477

Employees

5,800

EBITDA

194M

-924M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+80.75% upside

Dividends

By Dow Jones

Next Earnings

31 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-2.1B

10B

Previous open

22.25

Previous close

27.46

News Sentiment

By Acuity

100%

0%

368 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Moderna Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Jun 2025, 10:41 UTC

Major Market Movers

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine

31 Mar 2025, 14:19 UTC

Major Market Movers

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 Feb 2025, 18:52 UTC

Major Market Movers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

27 May 2025, 17:59 UTC

Top News

Kennedy, Skipping Regulatory Steps, Limits Use of Covid-19 Shots -- Barrons.com

12 May 2025, 22:14 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 May 2025, 18:45 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

12 May 2025, 17:14 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- WSJ

28 Apr 2025, 17:04 UTC

Earnings

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

28 Feb 2025, 12:00 UTC

Top News

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

24 Feb 2025, 10:17 UTC

Hot Stocks

Stocks to Watch Monday: Domino's, Berkshire Hathaway; Alibaba -- WSJ

14 Feb 2025, 22:04 UTC

Earnings

These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14 Feb 2025, 20:26 UTC

Earnings

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14 Feb 2025, 17:34 UTC

Earnings

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14 Feb 2025, 15:42 UTC

Earnings

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DraftKings, GameStop, and More -- Barrons.com

14 Feb 2025, 14:02 UTC

Top News
Earnings

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. -- Barrons.com

14 Feb 2025, 11:38 UTC

Top News
Earnings

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 Feb 2025, 11:34 UTC

Earnings

These Stocks Are Moving the Most Today: Intel, Airbnb, DraftKings, GameStop, Moderna, Roku, Palo Alto, and More -- Barrons.com

14 Feb 2025, 11:30 UTC

Top News
Earnings

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

4 Feb 2025, 19:34 UTC

Top News

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 Feb 2025, 18:51 UTC

Top News

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

21 Jan 2025, 10:12 UTC

Hot Stocks

Stocks to Watch Tuesday: MicroStrategy, Trump Media, Moderna, Ørsted -- WSJ

13 Jan 2025, 13:51 UTC

Earnings

Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast. -- Barrons.com

8 Jan 2025, 09:43 UTC

Hot Stocks

Stocks to Watch Wednesday: Moderna, Nvidia, Albertsons, Flutter -- WSJ

15 Nov 2024, 19:24 UTC

Earnings

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

15 Nov 2024, 17:23 UTC

Earnings

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

15 Nov 2024, 15:43 UTC

Earnings

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Alibaba, Bloom Energy, and More -- Barrons.com

15 Nov 2024, 13:34 UTC

Top News

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 Nov 2024, 13:08 UTC

Top News

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

15 Nov 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

15 Nov 2024, 10:34 UTC

Market Talk

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

Peer Comparison

Price change

Moderna Inc Forecast

Price Target

By TipRanks

80.75% upside

12 Months Forecast

Average 49.29 USD  80.75%

High 198 USD

Low 25 USD

Based on 20 Wall Street analysts offering 12 month price targets forModerna Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

20 ratings

4

Buy

13

Hold

3

Sell

Technical Score

By Trading Central

23.7 / 27.88Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

368 / 380 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.